These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22381030)

  • 1. Trastuzumab-induced cardiotoxicity: the role of two-dimensional myocardial strain imaging in diagnosis and management.
    Stoodley P; Tanous D; Richards D; Meikle S; Clarke J; Hui R; Thomas L
    Echocardiography; 2012 Jul; 29(6):E137-40. PubMed ID: 22381030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
    Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Trastuzumab-induced early cardiac dysfunction using two-dimensional Strain Echocardiography.
    Emren SV; Tuluce SY; Levent F; Tuluce K; Kalkan T; Yildiz Y; Alacacioğlu A; Kucukzeybek Y; Akyol M; Salman T
    Med Ultrason; 2015 Dec; 17(4):496-502. PubMed ID: 26649345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
    Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
    J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
    Hare JL; Brown JK; Leano R; Jenkins C; Woodward N; Marwick TH
    Am Heart J; 2009 Aug; 158(2):294-301. PubMed ID: 19619708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.
    Gong IY; Ong G; Brezden-Masley C; Dhir V; Deva DP; Chan KKW; Graham JJ; Chow CM; Thavendiranathan P; Dai D; Ng MY; Barfett JJ; Connelly KA; Yan AT
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):653-662. PubMed ID: 30390170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
    J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Hui R; Boyd A; Harnett PR; Meikle SR; Clarke J; Thomas L
    Eur J Echocardiogr; 2011 Dec; 12(12):945-52. PubMed ID: 21965152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
    Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
    Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
    Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
    J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction.
    Yu AF; Yadav NU; Eaton AA; Lung BY; Thaler HT; Liu JE; Hudis CA; Dang CT; Steingart RM
    Oncologist; 2015 Oct; 20(10):1105-10. PubMed ID: 26240135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab.
    Martins SJ; Modesto Dos Santos V; Thommen Teles L; Alves Leite V
    Rev Med Chil; 2012 Jun; 140(6):763-6. PubMed ID: 23282614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of early sub-clinical trastuzumab-induced cardiotoxicity in breast cancer patients.
    Dores H; Abecasis J; Correia MJ; Gândara F; Fonseca C; Azevedo J; Arroja I; Martins A; Mendes M
    Arq Bras Cardiol; 2013 Apr; 100(4):328-32. PubMed ID: 23525273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.
    Telli ML; Hunt SA; Carlson RW; Guardino AE
    J Clin Oncol; 2007 Aug; 25(23):3525-33. PubMed ID: 17687157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
    Ewer MS; Vooletich MT; Durand JB; Woods ML; Davis JR; Valero V; Lenihan DJ
    J Clin Oncol; 2005 Nov; 23(31):7820-6. PubMed ID: 16258084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer.
    Yu AF; Yadav NU; Lung BY; Eaton AA; Thaler HT; Hudis CA; Dang CT; Steingart RM
    Breast Cancer Res Treat; 2015 Jan; 149(2):489-95. PubMed ID: 25552363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in global left ventricular function by multidirectional strain assessment in heart failure patients undergoing cardiac resynchronization therapy.
    Delgado V; Ypenburg C; Zhang Q; Mollema SA; Fung JW; Schalij MJ; Yu CM; Bax JJ
    J Am Soc Echocardiogr; 2009 Jun; 22(6):688-94. PubMed ID: 19501328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speckle strain echocardiography predicts outcome in patients with heart failure with both depressed and preserved left ventricular ejection fraction.
    Stampehl MR; Mann DL; Nguyen JS; Cota F; Colmenares C; Dokainish H
    Echocardiography; 2015 Jan; 32(1):71-8. PubMed ID: 24816065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.
    Shaikh AY; Suryadevara S; Tripathi A; Ahmed M; Kane JL; Escobar J; Cerny J; Nath R; McManus DD; Shih J; McGuiness ME; Tighe DA; Meyer TE; Ramanathan M; Aurigemma GP
    Echocardiography; 2016 Aug; 33(8):1166-77. PubMed ID: 27109429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.